90
Participants
Start Date
November 25, 2019
Primary Completion Date
August 30, 2024
Study Completion Date
August 30, 2024
Stereotactic body radiotherapy
8 Gray x 3
Ipilimumab Injection [Yervoy]
1 mg/kg IV Q3W for four doses,
Nivolumab Injection [Opdivo]
Nivolumab 3mg/kg IV Q3W for four doses, then then Nivolumab 480mg IV Q4W
Biopsies
From soft tissue metastases.
Department of Oncology, Copenhagen University Hospital Herlev and Gentofte Hospital, Herlev
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Herlev and Gentofte Hospital
OTHER